Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022

SELL
$223.92 - $287.77 $178,464 - $229,352
-797 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$282.99 - $369.05 $23,488 - $30,631
-83 Reduced 9.43%
797 $225,000
Q2 2021

Jul 22, 2021

SELL
$259.0 - $414.71 $243,719 - $390,242
-941 Reduced 51.67%
880 $305,000
Q1 2021

Apr 20, 2021

BUY
$242.95 - $284.63 $23,566 - $27,609
97 Added 5.63%
1,821 $509,000
Q4 2020

Jan 20, 2021

SELL
$236.26 - $355.63 $4.26 Million - $6.42 Million
-18,043 Reduced 91.28%
1,724 $422,000
Q3 2020

Oct 16, 2020

BUY
$264.77 - $305.71 $112,792 - $130,232
426 Added 2.2%
19,767 $5.61 Million
Q2 2020

Jul 21, 2020

BUY
$258.66 - $342.55 $236,415 - $313,090
914 Added 4.96%
19,341 $5.18 Million
Q1 2020

Apr 17, 2020

BUY
$268.85 - $341.04 $194,916 - $247,254
725 Added 4.1%
18,427 $5.83 Million
Q4 2019

Feb 11, 2020

BUY
$220.06 - $304.07 $137,317 - $189,739
624 Added 3.65%
17,702 $5.25 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $15,003 - $16,827
69 Added 0.41%
17,078 $3.98 Million
Q2 2019

Jul 24, 2019

SELL
$219.29 - $241.72 $378,275 - $416,967
-1,725 Reduced 9.21%
17,009 $3.98 Million
Q1 2019

Apr 16, 2019

SELL
$216.71 - $338.96 $35,973 - $56,267
-166 Reduced 0.88%
18,734 $4.43 Million
Q4 2018

Feb 06, 2019

BUY
$278.5 - $352.75 $307,464 - $389,436
1,104 Added 6.2%
18,900 $5.69 Million
Q3 2018

Oct 12, 2018

BUY
$293.51 - $383.83 $113,294 - $148,158
386 Added 2.22%
17,796 $6.29 Million
Q2 2018

Jul 24, 2018

BUY
$257.52 - $306.91 $106,613 - $127,060
414 Added 2.44%
17,410 $5.05 Million
Q1 2018

May 04, 2018

BUY
$260.13 - $367.91 $521,820 - $738,027
2,006 Added 13.38%
16,996 $4.65 Million
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $112,903 - $126,460
-367 Reduced 2.39%
14,990 $4.78 Million
Q3 2017

Oct 13, 2017

BUY
$281.15 - $329.69 $4.32 Million - $5.06 Million
15,357
15,357 $4.81 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Busey Wealth Management Portfolio

Follow Busey Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.